USTEKINUMAB
ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe
USTEKINUMAB (14898D)
14898D
Manner of administration:Injection
Restriction
Indication: Severe Crohn disease
Treatment phase: Initial treatment - Initial 1 (new patient)
Restriction
Indication: Severe Crohn disease
Treatment phase: Initial treatment - Initial 2 (change or recommencement of treatment after a break
in biological medicine of less than 5 years)
Restriction
Indication: Severe Crohn disease
Treatment phase: Initial treatment - Initial 3 (recommencement of treatment after a break in biological
medicine of more than 5 years)
Restriction
Indication: Severe Crohn disease
Treatment phase: First continuing treatment
Restriction
Indication: Severe Crohn disease
Treatment phase: Balance of supply
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 2 | # of repeats: 0 | DPMQ: $1,570.68 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Steqeyma | |||||